Reputation data sourced from RepTrak, which surveys approximately 1,300 members of the general public that meet a familiarity threshold, scores their perceptions of a representative basket of biopharma firms and converts them to a 1-100 scale.

Pharma has never experienced a period offering as much potential for veneration ā€” or vilification ā€” as it did over the course of the past 18 months. With the world frantically searching for a way out of the COVID-19 crisis, the industry saw its reputation soar for the first time in years.

Read the full article here.